Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

CorrigendumAging Free access | 10.1172/JCI16510C1

Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs

Graciela Andonegui, Claudine S. Bonder, Francis Green, Sarah C. Mullaly, Lori Zbytnuik, Eko Raharjo, and Paul Kubes

Find articles by Andonegui, G. in: PubMed | Google Scholar

Find articles by Bonder, C. in: PubMed | Google Scholar

Find articles by Green, F. in: PubMed | Google Scholar

Find articles by Mullaly, S. in: PubMed | Google Scholar

Find articles by Zbytnuik, L. in: PubMed | Google Scholar

Find articles by Raharjo, E. in: PubMed | Google Scholar

Find articles by Kubes, P. in: PubMed | Google Scholar

Published October 15, 2003 - More info

Published in Volume 112, Issue 8 on October 15, 2003
J Clin Invest. 2003;112(8):1264–1264. https://doi.org/10.1172/JCI16510C1.
© 2003 The American Society for Clinical Investigation
Published October 15, 2003 - Version history
View PDF

Related article:

Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs
Graciela Andonegui, … , Eko Raharjo, Paul Kubes
Graciela Andonegui, … , Eko Raharjo, Paul Kubes
Article Aging

Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs

  • Text
  • PDF
Abstract

The rapid and selective accumulation of neutrophils into the lungs is thought to underlie the pulmonary failure that leads to sepsis-related death. In this study we investigated whether neutrophil TLR4 is important in LPS-induced pulmonary neutrophil recruitment by creating chimeric mice (transferring bone marrow between TLR4+/+ and TLR4–/– mice). In TLR4+/+ mice receiving TLR4–/– bone marrow, 6 weeks after transplant TLR4 was absent in all circulating leukocytes as well as in resident macrophages (these mice were termed LeukocyteTLR4–/–), and these cells were completely nonresponsive to LPS. In TLR4–/– mice receiving TLR4+/+ bone marrow, endothelial cells but not leukocytes were deficient in TLR4 (EndotheliumTLR4–/–). Surprisingly, systemic LPS (0.5 mg/kg) induced a dramatic increase in neutrophil sequestration into the lungs of LeukocyteTLR4–/– mice over the first 4 hours. Concomitantly, numbers of circulating leukocytes decreased by 90%. By contrast, EndotheliumTLR4–/– mice showed very little increase in neutrophil sequestration in the lungs, suggesting that endothelium rather than leukocyte TLR4 was important. Intravital microscopy of peripheral microcirculation in the cremaster muscle revealed about 30-fold more leukocyte–endothelial cell interactions in LPS-treated EndotheliumTLR4–/– mice than in LPS-treated LeukocyteTLR4–/– mice. This is consistent with less sequestration of leukocytes into the lungs of EndotheliumTLR4–/– mice. In conclusion, our data challenge the view that LPS directly activates neutrophils to trap in lungs and suggest a far more important role than previously appreciated for the endothelial cells.

Authors

Graciela Andonegui, Claudine S. Bonder, Francis Green, Sarah C. Mullaly, Lori Zbytnuik, Eko Raharjo, Paul Kubes

×

Original citation: J. Clin. Invest.112:1011–1020 (2003). doi:10.1172/JCI16510.

Citation for this erratum: J. Clin. Invest.112:1264 (2003). doi:10.1172/JCI16510C1.

On pages 1012 and 1015, The authors inadvertently referred to the mice lacking the TLR4 gene obtained from The Jackson Laboratory as generated TLR4 knockout mice. These mice are the naturally occurring knockout or null mutant (TLR4LPS-del) mice from The Jackson Laboratory, which, nevertheless, lack the gene, message, and protein.

Version history
  • Version 1 (October 15, 2003): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts